Kim Pettersson

High-sensitivity lateral flow immunoassay with a fluorescent lanthanide nanoparticle label (2019)

Journal of Immunological Methods

Teppo Salminen, Etvi Juntunen, Sheikh M. Talha, Kim Pettersson

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Clinical Utility of Mutant Antibody-Based Assays for Determination of Internally Cleaved and Intact Forms of Free Prostate-Specific Antigen (2019)

The Journal of Applied Laboratory Medicine

Khan MFL, Soikkeli M, Routila E, Krannila S, Terävä J, Taimen P, Boström PJ, Pettersson K

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Development of anti-immunocomplex specific antibodies and non-competitive time-resolved fluorescence immunoassay for the detection of estradiol (2019)

Analytical and Bioanalytical Chemistry

Leivo J., Kivimäki L., Juntunen E., Pettersson K., Lamminmäki U.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

CA125 glycoform assay improves the performance of conventional CA125 in the diagnostics of epithelial ovarian cancer (2018)

International Journal of Gynecological Cancer

Salminen L, Gidwani K, Rolfsen AL, Nadeem N, Bolstad N, Dorum A, Grenman S, Hietanen S, Perheentupa A, Poutanen M, Carpen O, Lamminmaki U, Pettersson K, Hynninen J, Huhtinen K

(O2 Muu julkaisu )

Microparticle - based platform for point-of-care immunoassays (2018)

Analytical Biochemistry

Teppo Salminen, Etvi Juntunen, Merja Lahdenranta, Iida Martiskainen, Sheikh M. Talha, Kim Pettersson

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A cancer-specific detection of serum CA125 improves differential diagnosis of epithelial ovarian cancer from benign conditions. (2018)

Clinical Cancer Research

Huhtinen K, Gidwani K, Kekki H, Hynninen J, Salminen L, Perheentupa A, Poutanen M, Auranen A, Grenman S, Lamminmaki U, Carpen O, Pettersson K

(O2 Muu julkaisu )

Direct immunoassay for free pregnancy-associated plasma protein A (PAPP-A) (2018)

The Journal of Applied Laboratory Medicine

Emilia Tuunainen, Juha Lund, Joanna Danielsson, Pirjo Pietilä, Veikko Wahlroos, Keira Pudge, Isto Leinonen, Pekka Porela, Tuomo Ilva, Mauri Lepäntalo, Kari Pulkki, Liisa-Maria Voipio-Pulkki, Kim Pettersson, Saara Wittfooth

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A lateral flow immunoassay with upconverting nanoparticle-based detection for indirect measurement of interferon response by the level of MxA (2017)

Journal of Medical Virology

Etvi Juntunen, Teppo Salminen, Sheikh Talha, Iida Martiskainen, Tero Soukka, Kim Pettersson, Matti Waris

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale (2017)

European Journal of Epidemiology

Auvinen A, Rannikko A, Taari K, Kujala P, Mirtti T, Kenttamies A, Rinta-Kiikka I, Lehtimaki T, Oksala N, Pettersson K, Tammela TL

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection (2017)

Clinical Biochemistry

Henna Kekki, Mari Peltola, Sandra van Vliet, Chris Bangma, Yvette van Kooyk, Kim Pettersson

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Publications

Sort by:

High-sensitivity lateral flow immunoassay with a fluorescent lanthanide nanoparticle label (2019)

Clinical Utility of Mutant Antibody-Based Assays for Determination of Internally Cleaved and Intact Forms of Free Prostate-Specific Antigen (2019)

Development of anti-immunocomplex specific antibodies and non-competitive time-resolved fluorescence immunoassay for the detection of estradiol (2019)

CA125 glycoform assay improves the performance of conventional CA125 in the diagnostics of epithelial ovarian cancer (2018)

Microparticle - based platform for point-of-care immunoassays (2018)

A cancer-specific detection of serum CA125 improves differential diagnosis of epithelial ovarian cancer from benign conditions. (2018)

Direct immunoassay for free pregnancy-associated plasma protein A (PAPP-A) (2018)

A lateral flow immunoassay with upconverting nanoparticle-based detection for indirect measurement of interferon response by the level of MxA (2017)

A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale (2017)

Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection (2017)